The Focal Electro-Oculogram in Macular Disease

黄斑疾病的局灶眼电图

基本信息

  • 批准号:
    9555712
  • 负责人:
  • 金额:
    $ 13.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Specific Aim 1: Develop a method for recording the focal EOG in response to a centrally presented light stimulus. A total of 20 healthy volunteers over the course of 1-3 study visits have participated in the study. Initial experiments to induce a dark trough before generating the light peak were shown to be highly variable. We shifted towards elimination of the dark trough in favor of generating a baseline dark amplitude during a long dark adaptation period of 40 minutes. For the light peak, we tested various stimulus sized and found that a 20o central stimulus was insufficient to generate a response from the target area, but a 40o central stimulus could produce the target response. Therefore, our current method is dark adaptation for 25 minutes, recording in the dark (to establish the baseline amplitude) for 20 minutes, then presentation of the light stimulus for 15 minutes. This method produces a recording lasting 35 minutes, which has been well-tolerated by all subjects. In order to test the response to centrally presented 40o light stimuli, volunteers were presented various central stimuli ranging from 10 to 150 cd/m2 in intensity. While 5/9 (56%) of eyes showed a light rise to 10 cd/m2, all 36 eyes tested showed light rises in response to intensities 40 cd/m2. Light peak:baseline averaged 1.370.19. Therefore, 40 cd/m2 appears to be the minimum 40 stimulus necessary and sufficient to generate a light rise. In order to test the variation in response to scattered light from central stimuli, various background intensities ranging from 0.4 cd/m2 to 1.1 cd/m2 were presented to volunteers. At the lowest background tested, participants had no or minimal light rise. The results above indicate that our method can measure an EOG light rise using a centrally presented 40 deg stimulus. The method for recording focal EOG requires that the background light be turned off for 10 seconds every minute. This is a departure from the standard focal EOG where the background remains on during the test. To determine whether these two methods produce different results, full-field EOGs were recorded from two healthy volunteers under identical conditions except for the two background conditions. The light rise portion of the intermittent background was within 10% of the continuously on-background indicating no meaningful difference between the background presentations. Specific Aim 2: Testing in healthy volunteers to determine intra- and inter-session variability. We have not yet attempted to measure variability in the focal EOG response. Specific Aim 3: Examine the focal EOG in participants with macular disease. We are currently enrolling maculopathy patients who meet specific criteria (central geographic atrophy, foveal preservation and a normal/near normal scotopic ERG) to test our hypothesis that a focal EOG is generated from the macula only with no scattered light component. Our initial results whilst promising were not sufficient to confirm that the focal EOG was truly a local response. In several participants, the focal EOG was absent and full-field EOG present as predicted. However, in the remaining Stargardt patients, there was a focal EOG of variable amplitude. We speculate that the size of atrophy was not a sufficiently large portion of the focal EOG stimulus size (40 deg) in some participants to sufficiently reduce the light rise response. We have expanded our recruitment to other participants with rare conditions affecting the macular, including one patient with variants in the melanogenesis associated transcription factor (MITF). We also recorded the focal EOG in a patient with a uveal coloboma. No focal EOG was recordable in this participant suggesting the focal EOG may be useful to examine participants with local defects in the retina/RPE complex. These results confirmed the utility of the technique to other conditions for whom it is unknown whether retina/RPE function is altered (e.g. MITF) or whether the extent of the malformation is sufficient to affect the focal EOG response (e.g. Uveal coloboma).
具体目标1:开发一种记录焦点EOG的方法,以响应集中呈现的光刺激。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brett Jeffrey其他文献

Brett Jeffrey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brett Jeffrey', 18)}}的其他基金

Rod and Cone Mediated Function in Retinal Disease
视杆细胞和视锥细胞在视网膜疾病中介导的功能
  • 批准号:
    10246743
  • 财政年份:
  • 资助金额:
    $ 13.13万
  • 项目类别:
Rod and Cone Mediated Function in Retinal Disease
视杆细胞和视锥细胞在视网膜疾病中介导的功能
  • 批准号:
    10930530
  • 财政年份:
  • 资助金额:
    $ 13.13万
  • 项目类别:
An Observational Cross-Sectional Study of Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
视网膜疾病功能性视觉虚拟现实移动性评估的观察横断面研究
  • 批准号:
    10706149
  • 财政年份:
  • 资助金额:
    $ 13.13万
  • 项目类别:
The Focal Electro-Oculogram in Macular Disease
黄斑疾病的局灶眼电图
  • 批准号:
    9362431
  • 财政年份:
  • 资助金额:
    $ 13.13万
  • 项目类别:
Color Vision in Inherited Retinal Degenerations
遗传性视网膜变性中的色觉
  • 批准号:
    8938363
  • 财政年份:
  • 资助金额:
    $ 13.13万
  • 项目类别:
Color Vision in Inherited Retinal Degenerations
遗传性视网膜变性中的色觉
  • 批准号:
    9155612
  • 财政年份:
  • 资助金额:
    $ 13.13万
  • 项目类别:
Color Vision in Inherited Retinal Degenerations
遗传性视网膜变性中的色觉
  • 批准号:
    9555700
  • 财政年份:
  • 资助金额:
    $ 13.13万
  • 项目类别:
Color Vision in Inherited Retinal Degenerations
遗传性视网膜变性中的色觉
  • 批准号:
    8737687
  • 财政年份:
  • 资助金额:
    $ 13.13万
  • 项目类别:
Rod and Cone Mediated Function in Retinal Disease
视杆细胞和视锥细胞在视网膜疾病中介导的功能
  • 批准号:
    9555713
  • 财政年份:
  • 资助金额:
    $ 13.13万
  • 项目类别:
An Observational Prospective Natural History Study of Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4
ELOVL4 突变继发的 Stargardt 样黄斑营养不良 (STDG3) 的观察性前瞻性自然史研究
  • 批准号:
    10706152
  • 财政年份:
  • 资助金额:
    $ 13.13万
  • 项目类别:

相似海外基金

I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
  • 批准号:
    10102692
  • 财政年份:
    2024
  • 资助金额:
    $ 13.13万
  • 项目类别:
    EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
  • 批准号:
    10639785
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
  • 批准号:
    23K09052
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
  • 批准号:
    10642988
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
  • 批准号:
    10584110
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
  • 批准号:
    22H03243
  • 财政年份:
    2022
  • 资助金额:
    $ 13.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
  • 批准号:
    10433610
  • 财政年份:
    2022
  • 资助金额:
    $ 13.13万
  • 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
  • 批准号:
    10504138
  • 财政年份:
    2022
  • 资助金额:
    $ 13.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了